-
公开(公告)号:US20230364426A1
公开(公告)日:2023-11-16
申请号:US18304876
申请日:2023-04-21
Applicant: Medtronic, Inc.
Inventor: Juan G. Hincapie , Eric J. Panken , Leonid M. Litvak , David A. Dinsmoor , Todd D. Zenisek , Andrew L. Schmeling , Andrew J. Cleland
CPC classification number: A61N1/36139 , A61N1/0551 , A61N1/025 , A61N1/3601 , A61N1/37258 , A61M5/1723 , A61M2205/054 , A61N1/3614 , A61N1/37288
Abstract: Processing circuitry for a medical system configured to determine posture and activity information of a patient and sense bioelectrical signals as well as receive information about the environment of the patient. The processing circuitry is configured to determine respiration activity of the patient based on the sensed signals and determine a degree of distress of the patient based on the sensed signals and the determined respiration activity. Responsive to determining the degree of distress, the processing circuitry is configured to output a command signal, which may adjust the output of stimulation circuitry configured to deliver electrical stimulation to a patient via a set of electrodes implanted proximal target tissue of the patient, upload the received information, cause the communication circuitry to send an electronic message comprising a notification of the degree of distress of the patient or take other actions.
-
公开(公告)号:US20230364425A1
公开(公告)日:2023-11-16
申请号:US18304816
申请日:2023-04-21
Applicant: Medtronic, Inc.
Inventor: Hank T. Bink , Erik J. Peterson , Jiashu Li , Vinod Sharma , Juan G. Hincapie , Eric J. Panken , Leonid M. Litvak , David A. Dinsmoor , Todd D. Zenisek , Andrew L. Schmeling , Andrew J. Cleland
CPC classification number: A61N1/36139 , A61N1/025 , A61N1/0551 , A61N1/36071 , A61N1/3614
Abstract: Processing circuitry of a system configured to determine a patient state based on sensed signals including posture and activity information and control delivery of electrical stimulation therapy to the patient via electrodes implanted proximal to target tissue of the patient. The sensed signals also include impedance measurement, and other bioelectrical signals, where sensing is interleaved with the electrical stimulation therapy. Responsive to determining the patient state, select an action, wherein the selected action comprises one or more of: store collected information, upload the collected information to an external computing device, and output an electronic signal comprising an alert.
-
公开(公告)号:US20230241400A1
公开(公告)日:2023-08-03
申请号:US18298179
申请日:2023-04-10
Applicant: Medtronic, Inc.
Inventor: Rene A. Molina , Scott R. Stanslaski , Jadin C. Jackson , Christopher L. Pulliam , Eric J. Panken , Michelle A. Case , Abbey Beuning Holt Becker
CPC classification number: A61N1/36139 , A61N1/36135 , A61N1/36067 , A61N1/36171 , A61N1/0534 , A61N1/3615
Abstract: Devices, systems, and techniques are described for identifying stimulation parameter values based on electrical stimulation that induces dyskinesia for the patient. For example, a method may include controlling, by processing circuitry, a medical device to deliver electrical stimulation to a portion of a brain of a patient, receiving, by the processing circuitry, information representative of an electrical signal sensed from the brain after delivery of the electrical stimulation, determining, by the processing circuitry and from the information representative of the electrical signal, a peak in a spectral power of the electrical signal at a second frequency lower than a first frequency of the electrical stimulation, and responsive to determining the peak in the spectral power of the electrical signal at the second frequency, performing, by the processing circuitry, an action.
-
公开(公告)号:US11666750B2
公开(公告)日:2023-06-06
申请号:US17107257
申请日:2020-11-30
Applicant: Medtronic, Inc.
Inventor: Scott R. Stanslaski , Thomas Adamski , Duane L. Bourget , Timothy J. Denison , Benjamin P. Isaacson , Eric J. Panken , Jeffrey Herron
CPC classification number: A61N1/0534 , A61B5/24 , A61B5/4836 , A61B5/4848 , A61B5/686 , A61B5/6868 , A61N1/36064 , A61N1/36067 , A61N1/36071 , A61N1/36082 , A61N1/36132 , A61N1/36135 , A61N1/36139 , A61N1/37247 , A61B5/0002 , A61N1/0476 , A61N1/36014 , A61N1/36096
Abstract: Techniques are disclosed for defining a homeostatic window for controlling delivery of electrical stimulation therapy to a patient. In one example, a method includes generating and delivering electrical stimulation therapy to tissue of a patient via electrodes. Further, the method includes adjusting a level of a parameter of the electrical stimulation therapy such that a signal of the patient is not less than a lower bound and not greater than an upper bound. The lower bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce one or more symptoms of a disease while the patient was receiving medication for reduction of the one or more symptoms. Further, the upper bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce the one or more symptoms when the patient was not receiving the medication.
-
公开(公告)号:US20220032059A1
公开(公告)日:2022-02-03
申请号:US16945639
申请日:2020-07-31
Applicant: Medtronic, Inc.
Inventor: Rene A. Molina , Scott R. Stanslaski , Jadin C. Jackson , Christopher L. Pulliam , Eric J. Panken , Michelle A. Case , Abbey Beuning Holt Becker
Abstract: Devices, systems, and techniques are described for identifying stimulation parameter values based on electrical stimulation that induces dyskinesia for the patient. For example, a method may include controlling, by processing circuitry, a medical device to deliver electrical stimulation to a portion of a brain of a patient, receiving, by the processing circuitry, information representative of an electrical signal sensed from the brain after delivery of the electrical stimulation, determining, by the processing circuitry and from the information representative of the electrical signal, a peak in a spectral power of the electrical signal at a second frequency lower than a first frequency of the electrical stimulation, and responsive to determining the peak in the spectral power of the electrical signal at the second frequency, performing, by the processing circuitry, an action.
-
公开(公告)号:US11135429B2
公开(公告)日:2021-10-05
申请号:US16395308
申请日:2019-04-26
Applicant: Medtronic, Inc.
Inventor: Eric J. Panken , Christopher L. Pulliam , Jadin C. Jackson , Yizi Xiao
IPC: A61B5/00 , A61B5/24 , A61B5/369 , A61N1/05 , A61N1/36 , A61N1/372 , G01B7/00 , G16H20/30 , G16H50/20 , G16H50/50
Abstract: Techniques are described to determine a location of at least one oscillatory signal source in a patient. Processing circuitry may determine expected electrical signal levels based on a hypothetical location of the at least one oscillatory signal source. Processing circuitry may determine the electrical signal levels and determine an error value based on the expected electrical signal levels and the determined electrical signal levels. Processing circuitry may adjust the hypothetical location of the at least one oscillatory signal source until the error value is less than or equal to a threshold value, including the example where the error value is minimized.
-
公开(公告)号:US20210093851A1
公开(公告)日:2021-04-01
申请号:US17107257
申请日:2020-11-30
Applicant: Medtronic, Inc.
Inventor: Scott R. Stanslaski , Thomas Adamski , Duane L. Bourget , Timothy J. Denison , Benjamin P. Isaacson , Eric J. Panken , Jeffrey Herron
Abstract: Techniques are disclosed for defining a homeostatic window for controlling delivery of electrical stimulation therapy to a patient. In one example, a method includes generating and delivering electrical stimulation therapy to tissue of a patient via electrodes. Further, the method includes adjusting a level of a parameter of the electrical stimulation therapy such that a signal of the patient is not less than a lower bound and not greater than an upper bound. The lower bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce one or more symptoms of a disease while the patient was receiving medication for reduction of the one or more symptoms. Further, the upper bound is determined to be the magnitude of the signal while receiving electrical stimulation therapy sufficient to reduce the one or more symptoms when the patient was not receiving the medication.
-
公开(公告)号:US20200338351A1
公开(公告)日:2020-10-29
申请号:US16395308
申请日:2019-04-26
Applicant: Medtronic, Inc.
Inventor: Eric J. Panken , Christopher L. Pulliam , Jadin C. Jackson , Yizi Xiao
Abstract: Techniques are described to determine a location of at least one oscillatory signal source in a patient. Processing circuitry may determine expected electrical signal levels based on a hypothetical location of the at least one oscillatory signal source. Processing circuitry may determine the electrical signal levels and determine an error value based on the expected electrical signal levels and the determined electrical signal levels. Processing circuitry may adjust the hypothetical location of the at least one oscillatory signal source until the error value is less than or equal to a threshold value, including the example where the error value is minimized.
-
公开(公告)号:US20200338350A1
公开(公告)日:2020-10-29
申请号:US16392129
申请日:2019-04-23
Applicant: Medtronic, Inc.
Inventor: Eric J. Panken , Jadin C. Jackson , Yizi Xiao , Christopher L. Pulliam
IPC: A61N1/36 , A61B5/00 , A61B5/0478 , A61N1/372 , A61N1/05
Abstract: Techniques are disclosed for using probabilistic entropy to select electrodes with fewer artifacts for controlling adaptive electrical neurostimulation. In one example, a plurality of electrodes sense bioelectrical signals of a brain of a patient. Processing circuitry determines, for each bioelectrical signal sensed at a respective electrode of the plurality of electrodes, a probabilistic entropy value of the bioelectrical signal. The processing circuitry compares each of the respective probabilistic entropy values of the bioelectrical signal to respective entropy threshold values and selects, based on the comparisons, a subset of electrodes of the plurality of electrodes. The processing circuitry controls, based on the bioelectrical signals sensed via respective electrodes of the subset of electrodes and excluding the bioelectrical signals of the plurality of bioelectrical signals sensed via respective electrodes not in the subset of electrodes, delivery of electrical stimulation therapy to the patient.
-
公开(公告)号:US10258798B2
公开(公告)日:2019-04-16
申请号:US15012646
申请日:2016-02-01
Applicant: Medtronic, Inc.
Inventor: Eric J. Panken , Timothy J. Denison , Gregory F. Molnar
Abstract: A patient controls the delivery of therapy through volitional inputs that are detected by a biosignal within the brain. The volitional patient input may be directed towards performing a specific physical or mental activity, such as moving a muscle or performing a mathematical calculation. In one embodiment, a biosignal detection module monitors an electroencephalogram (EEG) signal from within the brain of the patient and determines whether the EEG signal includes the biosignal. In one embodiment, the biosignal detection module analyzes one or more frequency components of the EEG signal. In this manner, the patient may adjust therapy delivery by providing a volitional input that is detected by brain signals, wherein the volitional input may not require the interaction with another device, thereby eliminating the need for an external programmer to adjust therapy delivery. Example therapies include electrical stimulation, drug delivery, and delivery of sensory cues.
-
-
-
-
-
-
-
-
-